OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of $1.01 billion. The enterprise value is $996.81 million.
Important Dates
The last earnings date was Wednesday, October 29, 2025, after market close.
| Earnings Date | Oct 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OPKO Health has 767.70 million shares outstanding. The number of shares has increased by 2.26% in one year.
| Current Share Class | 767.70M |
| Shares Outstanding | 767.70M |
| Shares Change (YoY) | +2.26% |
| Shares Change (QoQ) | -1.03% |
| Owned by Insiders (%) | 45.67% |
| Owned by Institutions (%) | 24.74% |
| Float | 319.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.50 |
| Forward PS | 1.82 |
| PB Ratio | 0.78 |
| P/TBV Ratio | 11.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.70, with a Debt / Equity ratio of 0.30.
| Current Ratio | 3.70 |
| Quick Ratio | 3.05 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.88 |
Financial Efficiency
Return on equity (ROE) is -13.32% and return on invested capital (ROIC) is -7.23%.
| Return on Equity (ROE) | -13.32% |
| Return on Assets (ROA) | -6.15% |
| Return on Invested Capital (ROIC) | -7.23% |
| Return on Capital Employed (ROCE) | -11.45% |
| Revenue Per Employee | $214,237 |
| Profits Per Employee | -$60,192 |
| Employee Count | 2,997 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 8.37 |
Taxes
In the past 12 months, OPKO Health has paid $20.89 million in taxes.
| Income Tax | 20.89M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.46% in the last 52 weeks. The beta is 1.34, so OPKO Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | -16.46% |
| 50-Day Moving Average | 1.44 |
| 200-Day Moving Average | 1.45 |
| Relative Strength Index (RSI) | 41.81 |
| Average Volume (20 Days) | 2,703,034 |
Short Selling Information
The latest short interest is 32.76 million, so 4.27% of the outstanding shares have been sold short.
| Short Interest | 32.76M |
| Short Previous Month | 33.37M |
| Short % of Shares Out | 4.27% |
| Short % of Float | 10.27% |
| Short Ratio (days to cover) | 18.44 |
Income Statement
In the last 12 months, OPKO Health had revenue of $642.07 million and -$180.40 million in losses. Loss per share was -$0.25.
| Revenue | 642.07M |
| Gross Profit | 121.55M |
| Operating Income | -209.11M |
| Pretax Income | -159.50M |
| Net Income | -180.40M |
| EBITDA | -115.81M |
| EBIT | -209.11M |
| Loss Per Share | -$0.25 |
Full Income StatementBalance Sheet
The company has $411.97 million in cash and $395.42 million in debt, giving a net cash position of $16.55 million or $0.02 per share.
| Cash & Cash Equivalents | 411.97M |
| Total Debt | 395.42M |
| Net Cash | 16.55M |
| Net Cash Per Share | $0.02 |
| Equity (Book Value) | 1.31B |
| Book Value Per Share | 1.70 |
| Working Capital | 457.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$197.03 million and capital expenditures -$15.03 million, giving a free cash flow of -$212.06 million.
| Operating Cash Flow | -197.03M |
| Capital Expenditures | -15.03M |
| Free Cash Flow | -212.06M |
| FCF Per Share | -$0.28 |
Full Cash Flow StatementMargins
Gross margin is 18.93%, with operating and profit margins of -32.57% and -28.10%.
| Gross Margin | 18.93% |
| Operating Margin | -32.57% |
| Pretax Margin | -24.84% |
| Profit Margin | -28.10% |
| EBITDA Margin | -18.04% |
| EBIT Margin | -32.57% |
| FCF Margin | n/a |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.26% |
| Shareholder Yield | -2.26% |
| Earnings Yield | -17.80% |
| FCF Yield | -20.93% |
Dividend DetailsAnalyst Forecast
The average price target for OPKO Health is $2.28, which is 72.73% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.28 |
| Price Target Difference | 72.73% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | -0.10% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OPKO Health has an Altman Z-Score of -0.41 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.41 |
| Piotroski F-Score | 2 |
